Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jane Henderson currently holds 175,371 shares of Akero Therapeutics, Inc. (AKRO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jane Henderson has been a net seller of AKRO stock. They have purchased $23.5K and sold $4.5M worth of shares.
Jane Henderson's most recent insider trade was on Apr 16, 2026, when they sold 2,000 shares at $90.00 per share.
Jane Henderson serves as Executive at Akero Therapeutics, Inc. (AKRO). They have executed 32 insider transactions totaling $4.5M over their tenure at the company.
Jane Henderson holds the position of Executive at Akero Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 18 years and currently hold a stake valued at $0.
Jane Henderson has shown a selling trading pattern, with $23.5K in total purchases and $4.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Jane Henderson was on Jun 16, 2023, when they sold $1.2M worth of AKRO shares. This transaction involved 22,498 shares at $54.46 per share.
Jane Henderson currently owns 175,371 shares of Akero Therapeutics, Inc. (AKRO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jane Henderson's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jane Henderson has 32 Form 4 filings on record as an insider at Akero Therapeutics, Inc..
Set alerts for Jane Henderson and 40,000+ other insiders.